Gene · 27329
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease. | Rev Cardiovasc Med | 2025 | 40026498 | PubTator, text mining | PubMed |
| Current and Emerging Treatment Options for Hypertriglyceridemia: State-of-the-Art Review. | Pharmaceuticals (Basel) | 2025 | 40005962 | PubTator, text mining | PubMed |
| RNA therapeutics in cardiovascular medicine. | Curr Opin Cardiol | 2025 | 39998478 | PubTator, text mining | PubMed |
| Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group. | Mol Ther Nucleic Acids | 2025 | 39991472 | PubTator, text mining | PubMed |
| Plasma proteome variation and its genetic determinants in children and adolescents. | Nat Genet | 2025 | 39972214 | PubTator, text mining | PubMed |
| Evinacumab as an adjunct to lipid apheresis in an infant with homozygous familial hypercholesterolemia. | J Pediatr Endocrinol Metab | 2025 | 39970166 | PubTator, text mining | PubMed |
| Relationship between the Composition of Urinary Calculi and Protein Biomarkers in Serum and Urine. | Arch Esp Urol | 2025 | 39943638 | PubTator, text mining | PubMed |
| Novel RNA-Based Therapies in the Management of Dyslipidemias. | Int J Mol Sci | 2025 | 39940794 | PubTator, text mining | PubMed |
| ANGPTL3 regulates the peroxisomal translocation of SmarcAL1 in response to cell growth states. | Sci Rep | 2025 | 39934259 | PubTator, text mining | PubMed |
| Genetic insights of lipid metabolism and lipid-lowering drugs with Lewy body dementia risk: Evidence from Mendelian randomization. | Prog Neuropsychopharmacol Biol Psychiatry | 2025 | 39929371 | PubTator, text mining | PubMed |
| Body Fat Distribution and Ectopic Fat Accumulation as Mediator of Diabetogenic Action of Lipid-Modifying Drugs: A Mediation Mendelian Randomization Study. | Mayo Clin Proc | 2025 | 39918451 | PubTator, text mining | PubMed |
| Identification and analysis of prognostic ion homeostasis characteristics in kidney renal clear cell carcinoma. | Heliyon | 2025 | 39897849 | PubTator, text mining | PubMed |
| The association of lipids and novel non-statin lipid-lowering drug target with osteoporosis: evidence from genetic correlations and Mendelian randomization. | BMC Musculoskelet Disord | 2025 | 39893413 | PubTator, text mining | PubMed |
| Multilayer regulation of postprandial triglyceride metabolism in response to acute cold exposure. | J Lipid Res | 2025 | 39892721 | PubTator, text mining | PubMed |
| Lipid Profile, PCSK9, ANGPTL3 and Lipoprotein (a) Levels in Men Diagnosed With Localized High-Grade Prostate Cancer and Men At-Risk of Prostate Cancer. | Cancer Med | 2025 | 39888285 | PubTator, text mining | PubMed |
| Circulating ANGPTL3/8 Concentrations Are Associated With an Atherogenic Lipoprotein Profile and Increased CHD Risk in Swedish Population-Based Studies. | Arterioscler Thromb Vasc Biol | 2025 | 39882603 | PubTator, text mining | PubMed |
| Chronic cold exposure reprograms feeding-regulated LPL activity in white adipose tissues through hepatic ANGPTL3 and ANGPTL8. | Life Metab | 2025 | 39872988 | PubTator, text mining | PubMed |
| Genetically mimicked effects of evinacumab on psoriasis: a drug target Mendelian randomization study. | Asia Pac J Clin Nutr | 2025 | 39828257 | PubTator, text mining | PubMed |
| Recent development in CRISPR-Cas systems for cardiac disease. | Prog Mol Biol Transl Sci | 2025 | 39824585 | PubTator, text mining | PubMed |
| Blocking ANGPTL3 and CD47 impact on atherosclerosis-correspondence. | Pharmacol Res | 2025 | 39818262 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27329/papers?page=13